Back to search
Fistulizing Crohns Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Fistulizing Crohns Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Fistulizing Crohns Disease trials you may qualify forThis is a double-blind, randomized, placebo-controlled, sequential cohort, ascending dose clinical trial to evaluate the safety and determine the efficacy of as…
This study will compare the efficacy and safety of TDM (therapeutic drug monitoring)-based infliximab (CT-P13, RemsimaTM) intravenous therapy compared with the…
The purpose of this study to evaluate the clinical efficacy of guselkumab in fistulizing, perianal Crohn's disease and to assess the overall safety of guselkuma…
In this study, participants with complex fistulizing conditions will be treated with surgical interventions according to their clinic's standard practice. The…
This study plans to enroll 10 patients aged 13-17 years of age with refractory perianal fistulizing disease. Patients will be treated by direct injection to the…